101 related articles for article (PubMed ID: 12046386)
1. [Regeneration of the esophagus epitheliocytes. Evaluation of pariet efficacy in the treatment of patients with reflux esophagitis].
Osadchuk MA; Lipatova TE; Chaplygin NV
Eksp Klin Gastroenterol; 2002; (2):43-6, 102. PubMed ID: 12046386
[TBL] [Abstract][Full Text] [Related]
2. [Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis].
Osadchuk MA; Lipatova TE; Chaplygin NV
Eksp Klin Gastroenterol; 2002; (4):23-6, 131. PubMed ID: 12503269
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type].
Ivanova NG
Eksp Klin Gastroenterol; 2002; (2):35-6, 101. PubMed ID: 12046384
[TBL] [Abstract][Full Text] [Related]
4. [Regeneration of the gastric epitheliocytes during treatment of duodenal ulcer with pariet].
Kulidzhanov AIu; Usik SF; Osadchuk MA; Kvetnoĭ IM; Kheĭlyk AI
Voen Med Zh; 2002 Apr; 323(4):38-42. PubMed ID: 12046531
[No Abstract] [Full Text] [Related]
5. [Graded therapy in reflux disease. "In severe cases 40 mg., in milder 20 mg."].
Gillessen A
MMW Fortschr Med; 2004 Mar; 146(11):54. PubMed ID: 15152771
[No Abstract] [Full Text] [Related]
6. Proton pump inhibitors.
Grover JK; Vats V
Trop Gastroenterol; 1999; 20(1):16-28. PubMed ID: 10464444
[No Abstract] [Full Text] [Related]
7. [Proton pump inhibitors in the treatment of reflux esophagitis].
Bigard MA
Rev Prat; 1994 Oct; 44(15):1992-6. PubMed ID: 7984887
[No Abstract] [Full Text] [Related]
8. [Pariet in current patterns of eradication of Helicobacter pylori infection].
Baranskaia EK
Voen Med Zh; 2001 Apr; 322(4):54-8. PubMed ID: 11547668
[No Abstract] [Full Text] [Related]
9. [A case of the successful treatment of the esophageal leukoplakia with rabeprazole].
Arutiunov AG; Burkov SG; Burdina EG; Svirchev VV
Eksp Klin Gastroenterol; 2002; (4):38-9, 131. PubMed ID: 12503273
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage)].
Vasil'ev IuV; Noskova KK; Zelenikin SA
Eksp Klin Gastroenterol; 2002; (1):55-60, 190. PubMed ID: 12271586
[TBL] [Abstract][Full Text] [Related]
11. Balanced perspective essential in erosive oesophagitis treatment.
Gillessen A
Aliment Pharmacol Ther; 2005 Nov; 22(9):889-90; author reply 890-1. PubMed ID: 16225500
[No Abstract] [Full Text] [Related]
12. [Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)].
Endo M; Sugihara K
Nihon Rinsho; 2000 Sep; 58(9):1865-70. PubMed ID: 11004817
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
[TBL] [Abstract][Full Text] [Related]
14. [Some comparative aspects of treating the gastroesophageal reflux disease eradication].
Minushkin ON; Maslovskiĭ LV; Anikina NIu
Eksp Klin Gastroenterol; 2004; (3):45-8, 104. PubMed ID: 15560401
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease].
Maev IV; Kucheriavyĭ IuA; Danilin MS
Eksp Klin Gastroenterol; 2003; (5):10-2, 192. PubMed ID: 14621603
[TBL] [Abstract][Full Text] [Related]
16. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
[TBL] [Abstract][Full Text] [Related]
17. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
DeVault KR
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():33-9. PubMed ID: 16483268
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
Gregor JC
Am J Manag Care; 2000 Aug; 6(8):934-5. PubMed ID: 11186505
[No Abstract] [Full Text] [Related]
19. Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux.
Calabrese C; Fabbri A; Bortolotti M; Cenacchi G; Carlo S; Zahlane D; Miglioli M; Di Febo G
World J Gastroenterol; 2005 Mar; 11(12):1876-80. PubMed ID: 15793885
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
Katz PO
Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
